Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
77 hedge funds and large institutions have $275M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 10 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
4% more funds holding
Funds holding: 74 → 77 (+3)
7% less capital invested
Capital invested by funds: $296M → $275M (-$20.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$8.29M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.48M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.87M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.6M |
| 5 |
BlackRock
New York
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NLVP
New Leaf Venture Partners
New York
|
-$7.31M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.66M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.29M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$3.17M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.49M |
OXFD Hedge Fund Activity: Q2 2018 in Review
77 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2018, worth a combined $275M — down 7% from $296M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new OXFD positions and 10 closed out — a net gain of 3 holders — while 32 added to existing stakes and 23 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $8.29M. The largest seller was New Leaf Venture Partners, cutting an estimated $7.31M.
- 77 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2018, up from 74 in Q1 2018.
- Funds reported $275M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2018, down 7% quarter-over-quarter.
- 13 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2018 and 10 closed out, a net change of +3 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2018 was First Light Asset Management, an estimated $8.29M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2018 was New Leaf Venture Partners, an estimated $7.31M sold.
Based on aggregated 13F filings for Q2 2018.